Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development

Journal of Steroid Biochemistry and Molecular Biology

Volumn 143, Issue , 2014, Pages 105-114

  Feferman, Leo ^a,b   Bhattacharyya, Sumit ^a,b   Birch, Lynn ^a   Prins, Gail S ^a   Tobacman, Joanne K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Chondroitin sulfate; Estradiol; Glycosaminoglycans; Steroid sulfatase; Sulfatase; Versican

Indexed keywords

CHONDROITIN 4 SULFATE; CHONDROITIN SULFATE; ESTRADIOL BENZOATE; ESTROGEN; GALACTOSE 6 SULFURYLASE; GLYCOSAMINOGLYCAN POLYSULFATE; N ACETYLGALACTOSAMINE 4 SULFATASE; N ACETYLGALACTOSAMINE 6 SULFATASE; PROTEOGLYCAN; SESAME SEED OIL; STERYL SULFATASE; SULFATASE; UNCLASSIFIED DRUG; VERSICAN; GLYCOSAMINOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ESTROGEN THERAPY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ORGANOGENESIS; PROSTATE; PROSTATE EPITHELIUM; PROSTATE VENTRAL LOBE; RAT; TISSUE HOMOGENATE; TREATMENT DURATION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME IMMUNOASSAY; ENZYMOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; METABOLISM; SPRAGUE DAWLEY RAT; STROMA CELL;

ANIMALS; CELLS, CULTURED; CHONDROITINSULFATASES; EPITHELIAL CELLS; ESTROGENS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSAMINOGLYCANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; MALE; N-ACETYLGALACTOSAMINE-4-SULFATASE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; STERYL-SULFATASE; STROMAL CELLS;

EID: 84896344082     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.01.017     Document Type: Article

References (38)

1. S. Bhattacharyya, and J.K. Tobacman Steroid sulfatase, arylsulfatases A and B, galactose 6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity J. Steroid Biochem. Mol. Biol. 103 1 2007 20 34 (Pubitemid 44821815)
2. L. Feferman, S. Bhattacharyya, R. Deaton, P. Gann, G. Guzman, A. Kajdacsy-Balla, and J.K. Tobacman Arylsulfatase B (N-acetylgalactosamine-4- sulfatase): potential role as a biomarker in prostate cancer Prostate Cancer Prostatic Dis. 2013 10.1038/pcan.2013.18 (Epub ahead of print)
3. S. Bhattacharyya, L. Feferman, and J.K. Tobacman Galectin-3 AP-1 mediate transcriptional effect of arylsulfatase B (N-acetylgalactosamine-4-sulfatase) on versican in prostate cancer Oncogene 2013 (Epub ahead of print)
4. S.V. Prabhu, S. Bhattacharyya, G. Guzman-Hartman, V. Macias, A. Kajdacsy-Balla, and J.K. Tobacman Extra-lysosomal localization of arylsulfatase B in human colonic epithelium J. Histochem. Cytochem. 59 3 2011 328 335
5. S. Bhattacharyya, K. Kotlo, S. Shukla, R.S. Danziger, and J.K. Tobacman Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfate J. Biol. Chem. 283 15 2008 9523 9530
6. S. Bhattacharyya, and J.K. Tobacman Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation Clin. Exp. Metastasis 26 6 2009 535 545
7. C. Ricciardelli, K. Mayne, P.J. Sykes, W.A. Raymond, K. McCaul, V.R. Marshall, W.D. Tilley, J.M. Skinner, and D.J. Horsfall Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer Clin. Cancer Res. 3 1997 983 992 (Pubitemid 27252948)
8. C. Ricciardelli, K. Mayne, P.J. Sykes, W.A. Raymond, K. McCaul, V.R. Marshall, and D.J. Horsfall Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer Clin. Cancer Res. 4 1998 963 971 (Pubitemid 28183398)
9. A.J. Sakko, C. Ricciardelli, K. Mayne, S. Suwiwat, R.G. LeBaron, V.R. Marshall, W.D. Tilley, and D.J. Horsfall Modulation of prostate cancer cell attachment to matrix by versican Cancer Res. 63 2003 4786 4791 (Pubitemid 37022606)
10. P. Kischel, D. Waltregny, B. Dumont, A. Turtoi, Y. Greffe, S. Kirsch, E. De Pauw, and V. Castronovo Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting Int. J. Cancer 126 2010 640 650
11. C. Ricciardelli, A.J. Sakko, M.P. Ween, D.L. Russell, and D.J. Horsfall The biological role and regulation of versican levels in cancer Cancer Metastasis Rev. 28 2009 233 245
12. G.S. Prins, and O. Putz Molecular signaling pathways that regulate prostate gland development Differentiation 76 2008 641 659 (Pubitemid 352032742)
13. G.S. Prins Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression Endocrinology 130 1992 3703 3714
14. G.S. Prins, and L. Birch The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen Endocrinology 136 1995 1303 1314
15. G.S. Prins, and L. Birch Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes Endocrinology 138 1997 1801 1809 (Pubitemid 27180792)
16. W.Y. Chang, M.J. Wilson, L. Birch, and G.S. Prins Neonatal estrogen stimulates proliferation of periductal fibroblasts and alters the extracellular matrix composition in the rat prostate Endocrinology 140 1999 405 415 (Pubitemid 29011186)
17. G.R. Cunha, W. Ricke, A. Thomson, P.C. Marker, G. Risbridger, S.W. Hayward, Y.Z. Wang, A.A. Donjacour, and T. Kurita Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development J. Steroid Biochem. Mol. Biol. 92 4 2004 221 236 (Pubitemid 40136583)
18. S. Bhattacharyya, D. Look, and J.K. Tobacman Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR Clin. Chim. Acta 380 1-2 2007 122 127 (Pubitemid 46498042)
19. A.B. Roy Arylsulfatases, colorimetric and fluorometric assays Methods Enzymol. 143 1987 207 217
20. B. Wolff, A. Billich, W. Brunowsky, G. Herzig, I. Lindley, P. Nussbaumer, E. Pursch, C. Rabeck, and G. Winkler Microtiter plate cellular assay for human steroid sulfatase with fluorescence readout Anal. Biochem. 318 2003 276 284 (Pubitemid 36694120)
21. O.P. van Diggelen, H. Zhao, W.J. Kleijer, B.J.H.M. Janse, J. Poorthuis, J. van Pelt, J.P. Kamerling, and H. Glajaard A fluorimetric enzyme assay for the diagnosis of Morquio disease type A Clin. Chim. Acta 187 1990 131 140
22. Blyscan™ Sulfated GAG Assay Bio. Bly. VER.03-12March2012int 2012 www.biocolor.co.uk
23. G.S. Prins, and L. Birch Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes Endocrinology 138 5 1997 1801 1809 (Pubitemid 27180792)
24. G.S. Prins, L. Birch, J.F. Couse, I. Choi, B. Katzenellenbogen, and K.S. Korach Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice Cancer Res. 61 16 2001 6089 6097 (Pubitemid 32762544)
25. G.S. Prins, L. Birch, W.Y. Tang, and S.M. Ho Developmental estrogen exposures predispose to prostate carcinogenesis with aging Reprod. Toxicol. 23 3 2007 374 382 (Pubitemid 46602925)
26. O. Putz, C.B. Schwartz, S. Kim, G.A. LeBlanc, R.L. Cooper, and G.S. Prins Neonatal low- and high-dose exposure to estradiol benzoate in the male rat: I. Effects on the prostate gland Biol. Reprod. 65 2001 1496 1505 (Pubitemid 33031508)
27. W.Y. Chang, L. Birch, C. Woodham, L. Gold, and G.S. Prins Neonatal estrogen exposure alters the TGFβ signaling system in the developing rat prostate and interrupts TGFß-mediated differentiation of the epithelium Endocrinology 140 1999 2801 2813 (Pubitemid 32245160)
28. H. Habermann, W.Y. Chang, L. Birch, P. Mehta, and G.S. Prins Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate Endocrinology 142 2001 359 369 (Pubitemid 32183697)
29. C.W. Frevert, M.G. Kinsella, C. Vathanaprida, R.B. Goodman, D.G. Baskin, A. Proudfoot, T.N. Wells, T.N. Wight, and T.R. Martin Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue Am. J. Respir. Cell Mol. Biol. 28 2003 464 472 (Pubitemid 36399368)
30. G.S. Kuschert, F. Coulin, C.A. Power, A.E. Proudfoot, R.E. Hubbard, A.J. Hoogewerf, and T.N. Wells Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses Biochemistry 38 1999 12959 12968
31. T.M. Handel, Z. Johnson, S.E. Crown, E.K. Lau, and A.E. Proudfoot Regulation of protein function by glycosaminoglycans - as exemplified by chemokines Annu. Rev. Biochem. 74 2005 385 410 (Pubitemid 40995512)
32. S. Bhattacharyya, and J.K. Tobacman Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia PLoS ONE 7 3 2012 e33250
33. D.J. Horsfall, K. Mayne, J.M. Skinner, G.T. Saccone, V.R. Marshall, and W.D. Tilley Glycosaminoglycans of guinea pig prostate fibromuscular stroma: influence of estrogen and androgen on levels and location of chondroitin sulfate Prostate 25 1994 320 332
34. A.J. Sakko, C. Ricciardelli, K. Mayne, M.T. Dours-Zimmermann, D.R. Zimmermann, P. Neufing, W.D. Tilley, V.R. Marshall, and D.J. Horsfall Changes in steroid receptors and proteoglycan expression in the guinea pig prostate stroma during puberty and hormone manipulation Prostate 67 2007 288 300
35. I.J. Edwards Proteoglycans in prostate cancer Nat. Rev. Urol. 9 2012 196 206
36. K.M. Lau, N.N. Tam, C. Thompson, R.Y. Cheng, Y.K. Leung, and S.M. Ho Age-associated changes in histology and gene-expression profile in the rat ventral prostate Lab. Invest. 83 2003 743 757 (Pubitemid 36618052)
37. R.A. Buresh-Stiemke, R.L. Malinowski, K.P. Keil, C.M. Vezina, A. Oosterhof, T.H. Van Kuppevelt, and P.C. Marker Distinct expression patterns of Sullf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development Dev. Dyn. 241 12 2012 2005 2013
38. R.A. Buresh, S.L. Kuslak, M.A. Rusch, C.M. Vezina, S.B. Selleck, and P.C. Marker Sulfatase 1 is an inhibitor of ductal morphogenesis with sexually dimorphic expression in the urogenital sinus Endocrinology 151 7 2010 3420 3431